Skip to content

Pneumatic Leg Compression and Norepinephrine Requirements in Patients Having Non-cardiac Surgery

Pneumatic Leg Compression and Norepinephrine Requirements in Patients Having Non-cardiac Surgery: a Pilot Monocentric Prospective Randomized Interventional Clinical Trial

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06950606
Acronym
PLANE
Enrollment
238
Registered
2025-04-30
Start date
2025-05-19
Completion date
2025-12-16
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypotension During Surgery

Keywords

Stressed volume, Vasopressor

Brief summary

The PLANE trial is a randomized, single-center trial investigating whether pneumatic leg compression reduces the amount of norepinephrine needed to keep MAP above 65mmHg compared to routine care without PLC in patients having non-cardiac surgery under general anesthesia

Interventions

DEVICEPneumatic leg compression

Patients assigned to the PLC group will receive a pneumatic leg compression sleeve encompassing the calf and thigh, with sleeve size adjusted according to thigh circumference and manufacturer recommendations. The compression pump will be activated before the start of surgery. After surgery, the responsible trial personnel will deactivate the pump and remove the compression sleeves in the PLC group. There will be no standardized anesthesia management protocol; all decisions regarding hemodynamic management will be made at the discretion of the treating anesthesiologist

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Consenting patients ≥45 years scheduled for elective non-cardiac surgery under general anesthesia that is expected to last ≥60 minutes

Exclusion criteria

Patients with the following

Design outcomes

Primary

MeasureTime frameDescription
Average norepinephrine infusion rateIntraoperativeAverage intraoperative norepinephrine infusion rate \[μg kg-1 min-1\] needed to keep MAP above 65mmHg. The average intraoperative norepinephrine infusion rate will be calculated using the absolute amount of norepinephrine administered per kg bodyweight \[μg kg-1\] divided by the duration of surgery (between surgical incision and suture) \[min\] (continuous outcome)

Secondary

MeasureTime frameDescription
Lowest intraoperative MAP [mmHg]IntraoperativeLowest intraoperative MAP \[mmHg\]
Cumulative intraoperative time with MAP <65 mmHg [min]IntraoperativeCumulative intraoperative time with MAP \<65 mmHg \[min\]
Intraoperative area under a MAP of 65 mmHgIntraoperativeIntraoperative area under a MAP of 65 mmHg
Intraoperative time-weighted average MAP <65 mmHg (area under a MAP of 65 mmHg divided by the monitoring time)IntraoperativeIntraoperative time-weighted average MAP \<65 mmHg (area under a MAP of 65 mmHg divided by the monitoring time)
Volume of crystalloid fluid given during surgery [ml]IntraoperativeVolume of crystalloid fluid given during surgery \[ml\]

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026